thiazoles has been researched along with balicatib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Black, WC; Cromlish, W; Desmarais, S; Falgueyret, JP; Khougaz, K; Lamontagne, S; Massé, F; Oballa, R; Percival, MD; Riendeau, D; Toulmond, S | 1 |
Bonnelye, E; Clézardin, P; Le Gall, C | 1 |
1 review(s) available for thiazoles and balicatib
Article | Year |
---|---|
Cathepsin K inhibitors as treatment of bone metastasis.
Topics: Azepines; Benzamides; Biphenyl Compounds; Bone Neoplasms; Bone Remodeling; Bone Resorption; Breast Neoplasms; Cathepsin K; Cathepsins; Female; Humans; Male; Osteoclasts; Piperazines; Prostatic Neoplasms; Sulfones; Thiazoles | 2008 |
1 other study(ies) available for thiazoles and balicatib
Article | Year |
---|---|
Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity.
Topics: Animals; Antigen Presentation; Autoradiography; Benzamides; Bone Density Conservation Agents; Cathepsin B; Cathepsin K; Cathepsin L; Cathepsins; Cell Line; Cysteine Endopeptidases; Female; Humans; Lysosomes; Mice; Mice, Inbred C57BL; Morpholines; Piperazines; Rabbits; Rats; Structure-Activity Relationship; Thiazoles; Tissue Distribution | 2005 |